Actively Recruiting
Adaptive Radiotherapy in Patients With Gynecological Tumors
Led by University Hospital, Essen · Updated on 2024-02-09
30
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective randomized evaluation of adaptive radiotherapy in the definitive radiotherapy of locally advanced gynecologic carcinoma (e.g. cervical carcinoma, endometrial carcinoma, vaginal carcinoma), in the postoperative situation or first series of external beam radiotherapy and in patients in whom radical surgery or HDR brachytherapy as dose boost is not an option.
CONDITIONS
Official Title
Adaptive Radiotherapy in Patients With Gynecological Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ECOG performance status 0-1
- Confirmed diagnosis by histopathology
- Pelvic MRI staging performed
You will not qualify if you...
- Recurrent disease
- Prior radiotherapy in the pelvic region
- Presence of distant metastases (stage pM1 or cM1)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department for Radiotherapy, University Hospital Essen, National Center for Tumor Diseases (NCT) West
Essen, Germany / NRW, Germany, 45147
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here